Avoro Capital Advisors LLC lifted its stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 65.2% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 4,222,222 shares of the company’s stock after acquiring an additional 1,666,667 shares during the quarter. Syndax Pharmaceuticals comprises approximately 1.3% of Avoro Capital Advisors LLC’s portfolio, making […]
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) – Stock analysts at B. Riley lifted their Q2 2024 earnings per share estimates for shares of Syndax Pharmaceuticals in a research note issued on Thursday, May 9th. B. Riley analyst K. Patel now forecasts that the company will earn ($0.96) per share for the quarter, up from […]
Syndax Pharmaceuticals (NASDAQ:SNDX) PT Lowered to $30 00 at Citigroup modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.
Syndax Pharmaceuticals (SNDX) Buy Rating Reiterated at HC Wainwright theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright reaffirmed their buy rating on shares of Syndax Pharmaceuticals (NASDAQ:SNDX – Free Report) in a report released on Friday, Benzinga reports. HC Wainwright currently has a $41.00 price target on the stock. A number of other research firms have also weighed in on SNDX. StockNews.com upgraded shares of Syndax Pharmaceuticals to a sell […]